Received for publication July 12, 2005.
Revised September 16, 2005.
Accepted for publication September 16, 2005.

Pharmacological Characterisation of Agonists at -containing GABA_A Receptors: Functional Selectivity for Extrasynaptic Receptors is Dependent on Absence of ₂

Abstract

Several groups have characterized the pharmacology of ₄- or ₆₃ containing GABA_A receptors expressed in different cell systems. We have previously demonstrated that the pharmacological profiles of a series of GABA_A receptor agonists are highly dependent on the subunit and little on the and the subunit, so in order to further understand the contribution of the different subunits in the GABA_A receptor complex, we characterized a series of full agonists, partial agonists and antagonists at ₄₃, ₄₃ and ₆₃ receptors expressed in Xenopus oocytes. Little or no difference was seen, when the compounds were compared at and containing receptors, whereas a significant reduction in both potency and relative efficacy was observed, compared to containing receptors described in the literature. These data clearly confirm that the presence of the subunit in heterotrimeric receptors is a strong determinant of the increased pharmacological activity of compounds with agonist activity. The very similar agonist pharmacology of and containing receptors, which is significantly different from containing receptors, show that whereas the presence of a subunit impairs the response to an agonist stimulation of the receptor complex, the subunit does not affect this in any way. Taken together, these data are well in line with the idea that ₄₃ may contribute to the pharmacological action of exogenously applied agonists and may explain why systemically active compounds like gaboxadol and muscimol in vivo appear to act as a selective extrasynaptic GABA_A agonists (SEGA).

Key words: SEGA, electrophysiology, extrasynaptic receptors, gaboxadol, oocytes, sleep agent

This article has been cited by other articles:

				E. I. Krook-Magnuson, P. Li, S. M. Paluszkiewicz, and M. M. Huntsman Tonically Active Inhibition Selectively Controls Feedforward Circuits in Mouse Barrel Cortex J Neurophysiol, August 1, 2008; 100(2): 932 - 944. [Abstract] [Full Text] [PDF]

				W. Hevers, S. H. Hadley, H. Luddens, and J. Amin Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing {alpha}6 and {delta} Subunits J. Neurosci., May 14, 2008; 28(20): 5383 - 5393. [Abstract] [Full Text] [PDF]

				F. Jia, M. Yue, D. Chandra, G. E. Homanics, P. A. Goldstein, and N. L. Harrison Isoflurane Is a Potent Modulator of Extrasynaptic GABAA Receptors in the Thalamus J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1127 - 1135. [Abstract] [Full Text] [PDF]

				N. P. Barrera, J. Betts, H. You, R. M. Henderson, I. L. Martin, S. M. J. Dunn, and J. M. Edwardson Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the {alpha}4{beta}3{delta} GABAA Receptor Mol. Pharmacol., March 1, 2008; 73(3): 960 - 967. [Abstract] [Full Text] [PDF]

				M. B. Herd, A. R. Haythornthwaite, T. W. Rosahl, K. A. Wafford, G. E. Homanics, J. J. Lambert, and D. Belelli The expression of GABAA {beta} subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells J. Physiol., February 15, 2008; 586(4): 989 - 1004. [Abstract] [Full Text] [PDF]

				K. K. Ade, M. J. Janssen, P. I. Ortinski, and S. Vicini Differential Tonic GABA Conductances in Striatal Medium Spiny Neurons J. Neurosci., January 30, 2008; 28(5): 1185 - 1197. [Abstract] [Full Text] [PDF]

				F. Jia, M. Yue, D. Chandra, A. Keramidas, P. A. Goldstein, G. E. Homanics, and N. L. Harrison Taurine Is a Potent Activator of Extrasynaptic GABAA Receptors in the Thalamus J. Neurosci., January 2, 2008; 28(1): 106 - 115. [Abstract] [Full Text] [PDF]